ImageneBio (IMA) Total Current Liabilities (2020 - 2025)

ImageneBio has disclosed Total Current Liabilities across 6 years of filings, most recently posting $11.2 million for Q4 2025.

• In Q4 2025, Total Current Liabilities fell 34.72% year-over-year to $11.2 million; the TTM figure through Dec 2025 stood at $11.2 million (down 34.72% YoY), while the FY2025 annual figure was $11.2 million, down 34.72% from the prior year.
• Total Current Liabilities came in at $11.2 million for Q4 2025 at ImageneBio, up from $11.1 million in the prior quarter.
• In the past five years, Total Current Liabilities ranged from a high of $30.6 million in Q3 2021 to a low of $7.3 million in Q2 2025.
• Average Total Current Liabilities over 5 years is $18.1 million, with a median of $15.7 million recorded in 2023.
• Year-over-year, Total Current Liabilities plunged 57.89% in 2023 and gained 21.15% in 2024.
• Over 5 years, Total Current Liabilities stood at $27.2 million in 2021, then dropped by 20.91% to $21.5 million in 2022, then plunged by 33.94% to $14.2 million in 2023, then climbed by 21.15% to $17.2 million in 2024, then tumbled by 34.72% to $11.2 million in 2025.
• Per Business Quant data, the three most recent Total Current Liabilities figures were $11.2 million in Q4 2025, $11.1 million in Q3 2025, and $7.3 million in Q2 2025.